Skip to content

Gregory B. Pehling, MD

NPI 1871595116ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· La Crosse, WI

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in La Crosse, Wisconsin, licensed in WI, with an NPI issued in June 2005. Part D covered 361 prescriptions written in 2024, 58% of them generic. Gilead Sciences, Inc. was the largest of 5 companies reporting payments in 2025, $193.74 in all, mostly food and beverage.

Overview

NPI1871595116
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 1, 2005
Last updated in NPPESMay 24, 2019

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)361 · 854 30-day fills
Patients34
Total drug cost$115,994
Generic share58% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$193.74 · 5 payments from 5 companies
  • 2024$152.39 · 9 payments from 5 companies

Top paying companies in 2025

CompanyAmountPayments
Gilead Sciences, Inc.$125.001
Corcept Therapeutics$20.061
Novo Nordisk Inc$17.841
Abbvie Inc.$15.921
Lilly USA, LLC$14.921

What the 2025 payments were for

  • Food and Beverage$193.74 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in La Crosse

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Wisconsin →